000 | 01105 a2200301 4500 | ||
---|---|---|---|
005 | 20250512035613.0 | ||
264 | 0 | _c19881216 | |
008 | 198812s 0 0 eng d | ||
022 | _a0361-090X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHadden, J W | |
245 | 0 | 0 |
_aRecent advances in the preclinical and clinical immunopharmacology of interleukin-2: emphasis on IL-2 as an immunorestorative agent. _h[electronic resource] |
260 |
_bCancer detection and prevention _c1988 |
||
300 |
_a537-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xtherapy |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmune System _xdrug effects |
650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
650 | 0 | 4 |
_aInterleukin-2 _xpharmacokinetics |
650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeoplasms _xtherapy |
650 | 0 | 4 |
_aNeoplasms, Experimental _xtherapy |
773 | 0 |
_tCancer detection and prevention _gvol. 12 _gno. 1-6 _gp. 537-52 |
|
999 |
_c3146850 _d3146850 |